Skip to main content
Journal of Multidisciplinary Healthcare logoLink to Journal of Multidisciplinary Healthcare
. 2026 Nov 11;19:647499. doi: 10.2147/JMDH.S647499

Best Evidence Summary of Phase II Exercise-Based Cardiac Rehabilitation for Patients with Dilated Cardiomyopathy After Cardiac Resynchronization Therapy

Xinglei Wang 1,2,*, Yunyun Liu 2,*, Leyao Han 3, Haixia Wang 4, Meishan Zhang 5, Yaya Xi 2, Jingying Xiong 2, Xinman Dou 2,6,✉
PMCID: PMC13770528  PMID: 43036757

Abstract

Background

This study aimed to systematically summarize the available evidence on Phase II exercise-based cardiac rehabilitation (CR) for patients with dilated cardiomyopathy (DCM) after cardiac resynchronization therapy (CRT), so as to provide an evidence-based framework for clinical nursing practice.

Methods

A comprehensive computerized search was conducted in PubMed, Embase, Cochrane Library, CINAHL, Web of Science, CNKI, WanFang, VIP, and SinoMed, as well as guideline repositories, evidence-based databases, and professional association websites. The included document types were clinical decisions, guidelines, expert consensus or consensus documents, evidence summaries and systematic reviews.

Results

Twenty-eight publications were included: 2 clinical decisions, 10 guidelines, 1 systematic review, 11 expert consensus or consensus documents and 4 evidence summaries. A total of 42 pieces of evidence items were summarized across 12 themes: multidisciplinary collaboration, indications and contraindications for exercise rehabilitation, pre-exercise assessment, pre-exercise preparation, exercise prescription, aerobic exercise, resistance training; pulmonary rehabilitation training, flexibility training, personalized adjustment, remote supervision and support, and emergency management.

Conclusion

This study synthesized available evidence on Phase II exercise-based CR for patients with DCM after CRT. Most included evidence was derived from broader heart failure or cardiac rehabilitation populations; direct evidence specific to DCM after CRT remains limited. These findings may inform the development of individualized rehabilitation protocols, but recommendations should be applied with caution.

Registration

This evidence summary was registered with the Fudan University Center for Evidence-Based Nursing (Registration No. ES202610091).

Keywords: dilated cardiomyopathy, cardiac resynchronization therapy, cardiac rehabilitation, exercise rehabilitation, evidence summary

Introduction

Dilated cardiomyopathy (DCM) is primarily characterized by ventricular dilation and impaired myocardial contractility, and its diagnosis requires excluding cardiac enlargement caused by other conditions, such as hypertension, valvular heart disease, congenital heart disease, and coronary atherosclerosis.1 Clinical features of DCM include reduced left ventricular ejection fraction (LVEF), heart failure, arrhythmias, thromboembolism, and sudden cardiac death. With an increasing incidence, affecting around 1 in 250 individuals, DCM has become the third most common cause of heart failure.2 Cardiac resynchronization therapy (CRT) is a crucial intervention for patients with DCM, as it can correct ventricular electromechanical dyssynchrony, thereby improving cardiac function and reducing mortality. Specifically, CRT can significantly increase LVEF, reduce the risk of heart failure rehospitalization, and enhance quality of life.3 However, not all patients with DCM derive benefit from CRT. Benefit is mainly observed in symptomatic patients with heart failure with reduced ejection fraction (HFrEF), LVEF ≤35%, sinus rhythm, and QRS duration ≥130 ms who are receiving guideline-directed medical therapy, as most major randomized controlled trials (RCT) were restricted to patients in sinus rhythm.3 In addition, approximately 30% of patients exhibit early non-response to the implanted device,4,5 and some may develop complications such as physical discomfort, lead abnormalities, and sensing dysfunction, with untimely postoperative management being a contributing factor.6 Therefore, long-term optimization of device parameters, standardized medication, and adherence to follow-up are required, making strengthened postoperative management particularly important.6

Cardiac rehabilitation (CR) is a comprehensive, medically supervised intervention that integrates five core prescriptions, namely exercise, nutrition, psychological support, smoking cessation, and medication, to help patients with cardiovascular disease achieve healthy living and disease management goals, optimize physical function, improve quality of life, and reduce recurrent major cardiovascular and cerebrovascular events.7 The standard CR model mainly comprises three phases: Phase I (inpatient rehabilitation), Phase II (early outpatient or out-of-hospital rehabilitation), and Phase III (long-term out-of-hospital, community, or home-based rehabilitation).8 Phase II exercise-based CR, the cornerstone of CR, is a critical component of post-CRT management in patients with DCM.8 Evidence suggests that appropriately prescribed Phase II exercise-based CR may increase the 6-minute walk test (6MWT), improve LVEF, and reduce rehospitalization rates among patients with DCM after CRT.9 Nevertheless, some studies have indicated that high-intensity exercise and competitive sports may trigger serious arrhythmias in this population.3 Despite these findings, current clinical practice lacks standardized guidance on the essential components of Phase II exercise-based CR for post-CRT patients with DCM, including exercise intensity, type, duration, and safety monitoring parameters. Furthermore, high-quality evidence is scarce regarding how to balance the efficacy and safety of exercise-based CR in this cohort and how to enhance patient adherence to rehabilitation protocols. Patients with DCM after CRT represent a distinct subgroup with device-related risks, arrhythmic susceptibility, dynamic changes in cardiac function, and high rates of psychological distress and poor adherence.3,5,6 However, most guidelines and trials have enrolled broader heart failure populations, and evidence specific to Phase II exercise-based cardiac rehabilitation in this group remains limited.

This study aimed to systematically summarize the best available evidence on Phase II exercise-based CR for patients with DCM after CRT. The evidence types included clinical decisions, guidelines, expert consensus or consensus documents, evidence summaries, and systematic reviews. We sought to identify key components such as exercise prescription, safety monitoring, and adherence-promoting strategies, and to provide a practical basis for evidence-based nursing practice.

Methods

This study was conducted as an evidence summary using evidence-based methodology. A systematic search was performed in computerized decision support systems (BMJ Best Practice, UpToDate), guideline websites (JBI, GIN, www.guidelines-registry.org, NGC, AHRQ, WHO, NICE, SIGN, NZGG, CMA Infobase, Medlive), professional association websites (CSC, http://www.nccd.org.cn, AHA, AACVPR, ACC, ESC, CSANZ, JCS, RNAO, CCS), and databases (CNKI, Wanfang Database, VIP Database, SinoMed, PubMed, Web of Science, Embase, Cochrane Library). The search period was from database establishment to January 1st, 2025. The retrieved literature underwent quality appraisal, evidence extraction, and synthesis.

Problem Establishment

This study examined an evidence-based question utilizing the PIPOST framework:10 (1) P (Population): The study population consists of patients aged ≥18 years with DCM who have undergone CRT; (2) I (Intervention): The interventions include various recommendations and measures related to phase II exercise rehabilitation; (3) P (Professional): The target practitioners are specifically clinical healthcare professionals; (4) O (Outcome): The outcome indicators encompass cardiorespiratory function and quality of life, among others; (5) S (Setting): The settings for evidence application include inpatient wards, outpatient clinics, rehabilitation centers, community facilities, and home-based environments; (6) T (Type of evidence): The types of evidence considered include clinical decisions, guidelines, expert consensus or consensus documents, evidence summaries, and systematic reviews.

Evidence Retrieval

Two researchers independently conducted the literature search using a combination of subject headings and free-text terms. In accordance with the EBHC 5.0 evidence model,11 a hierarchical search was performed across computerized decision support systems, guideline websites, professional association websites, and bibliographic databases. An example of an English database search using PubMed with the corresponding search strategy is shown in Table 1, and the search strategy described in Table 2.

Table 1.

Literature Search Strategy of PubMed

#1 “cardiac rehabilitation”[MeSH Terms] OR “exercise therapy”[MeSH Terms] OR “sports”[MeSH Terms] OR “exercise”[MeSH Terms]
#2 “cardiac rehabilitation*”[Title/Abstract] OR “cardiovascular rehabilitation*”[Title/Abstract] OR “CR”[Title/Abstract] OR “athletic*”[Title/Abstract] OR “sport*”[Title/Abstract] OR “rehabilitation exercise*”[Title/Abstract] OR “exercise therap*”[Title/Abstract] OR “remedial exercise*”[Title/Abstract] OR “exercise training*”[Title/Abstract] OR “aerobic exercise*”[Title/Abstract] OR “physical activit*”[Title/Abstract] OR “motion therapy”[Title/Abstract] OR “resistance exercise”[Title/Abstract] OR “aerobics”[Title/Abstract] OR “exercise test”[Title/Abstract]
#3 #1 OR #2
#4 “cardiac resynchronization therapy”[MeSH Terms]
#5 “cardiac resynchronization pacing therapy”[Title/Abstract] OR “atrio biventricular pacing”[Title/Abstract] OR “biventricular pacing”[Title/Abstract] OR “CRT”[Title/Abstract]
#6 #4 OR #5
#7 “cardiomyopathy, dilated”[MeSH Terms] OR “heart failure”[MeSH Terms]
#8 “dilated cardiomyopath*”[Title/Abstract] OR “familial idiopathic cardiomyopath*”[Title/Abstract] OR “congestive cardiomyopath*”[Title/Abstract] OR “idiopathic dilated cardiomyopath*”[Title/Abstract] OR “DCM”[Title/Abstract] OR “cardiac failure”[Title/Abstract] OR “heart decompensation”[Title/Abstract] OR “congestive heart failure”[Title/Abstract] OR “right sided heart failure”[Title/Abstract] OR “left sided heart failure”[Title/Abstract] OR “myocardial failure”[Title/Abstract]
#9 #7 OR #8
#10 #3 AND #6 AND #9

Table 2.

Search Strategy Used in the Summary of Evidence

Terms Contents
Search Terms Dilated Cardiomyopathy, DCM, Familial Idiopathic Cardiomyopathy, Congestive Cardiomyopathy, Idiopathic Dilated Cardiomyopathy; Cardiac Resynchronization Therapy, CRT, Atrio Biventricular Pacing, Biventricular Pacing; Cardiac Rehabilitation, Secondary Prevention, Sports, Exercise
Computerized Decision Support BMJ Best Practice; UpToDate
Guideline Websites Joanna Briggs Institute (JBI), Guidelines International Network (GIN), www.guidelines-registry.org, National Guideline Clearinghouse (NGC), Agency for Healthcare Research and Quality (AHRQ), World Health Organization (WHO), National Institute for Health and Clinical Excellence (NICE), Scottish Intercollegiate Guidelines Network(SIGN), New Zealand Guidelines Group (NZGG), Canadian Medical Association Infobase (CMA Infobase), Medlive
Websites of Cardiovascular Professional Associations Chinese Society of Cardiology(CSC), http://www.nccd.org.cn, American Heart Association(AHA), American Association of Cardiovascular and Pulmonary Rehabilitation(AACVPR), American College of Cardiology(ACC), European Society of Cardiology(ESC), Cardiac Society of Australia and New Zealand(CSANZ), Japanese Circulation Society (JCS), Registered Nurses’ Association of Ontario(RNAO), Canadian Cardiovascular Society(CCS)
Databases CNKI, Wanfang Database, VIP Database, SinoMed, PubMed, Web of Science, Embase, Cochrane Library
Time The search deadline was from database establishment to January 1st, 2025.

Inclusion and Exclusion Criteria of Evidences

Inclusion criteria: (1) Population: adults aged ≥18 years with DCM who had undergone CRT; (2) Intervention: Phase II exercise-based CR; (3) Study type: clinical decisions, guidelines, expert consensus or consensus documents, evidence summaries and systematic reviews; (4) For studies enrolling broader heart failure populations, only data specifically for DCM or CRT subgroups were extracted when available. If subgroup data were unavailable, the evidence was considered indirect and downgraded; (5) For documents with multiple versions, the most recent version was selected; (6) Publications in Chinese or English.

Exclusion Criteria: (1) Translations of original documents, interpretations of guidelines or consensuses, draft versions, directive documents, and conference abstracts; (2) Duplicate publications; (3) Studies lacking complete data, insufficient documentation, or unclear outcome measures.

Literature Screening

The search results were imported into EndNote X9 to eliminate duplicates. Following this, two reviewers screened the titles, abstracts, and keywords of the retrieved records independently, excluding entries that did not meet the specified criteria. Full texts of the retained citations were then assessed for eligibility. Any discrepancies were resolved through discussion within the research team. If consensus was not reached, a third reviewer was consulted for arbitration.

Quality Evaluation of the Literature

Given the variations in content, structure, and methodology across different document types, appropriate critical appraisal tools were selected to assess the quality of each type of literature. Before evaluation, an evidence-based nursing expert interpreted the specific criteria for each tool, providing illustrative examples. For systematic reviews, expert consensuses, clinical decisions, and evidence summaries, the quality appraisal was conducted independently by two researchers. Disagreements were resolved by re-examining the source document, discussing their rationale, and consulting a third specialist for final adjudication. The third specialist had a master’s degree or above in nursing, had received systematic evidence-based nursing training, and had experience in evidence summary methodology.

The choice of appraisal instruments varied by evidence source type. Quality evaluation criteria for clinical guidelines involve assessing the quality of the included guidelines based on the Appraisal of Guidelines for Research and Evaluation II (AGREE II).12 Each item is rated on a scale from 1 to 7, where a score of 1 indicates complete non-compliance and a score of 7 indicates complete compliance. The standardized score for each domain is calculated as the percentage of the highest possible score within that domain; thus, a higher score reflects higher quality guidelines. The standardized score for each domain was calculated as follows: [(actual score - lowest possible score) / (highest possible score - lowest possible score)] × 100%. Recommendations from the guidelines are categorized into three levels: A-level (strong recommendation) is assigned to guidelines with scores of ≥ 60% across all six domains; B-level (recommended) applies to domains scoring < 60%, provided that at least three domains score ≥ 30%; and C-level (not recommended) is designated for guidelines with scores < 30% in three or more domains. Systematic reviews and expert consensus were appraised using the JBI critical appraisal tools.13 Each item was evaluated as “Yes”, “No”, “Unclear” or “Not Applicable”. Clinical decisions and evidence summaries were appraised using the Summaries of Evidence (CASE) tool.14

Method for Forming Evidence Level and Recommendation Level

Two researchers from the team individually assessed every article included and consolidated the evidence based on thematic categories. The synthesis of evidence followed specific principles: (1) Exclusion of irrelevant evidence to the research topic; (2) Integration of similar or overlapping evidence; (3) Resolution of conflicting evidence by giving precedence to systematic reviews and meta-analyses, higher-quality evidence, recent publications, and clinical guidelines. Any discrepancies were resolved through discussion within the research team. If consensus was not reached, a third reviewer adjudicated.

Evidence from guidelines was appraised using AGREE II; systematic reviews and expert consensus were appraised using the JBI critical appraisal tools; clinical decisions and evidence summaries were appraised using the CASE tool. The level of evidence was determined based on the study design of the source document. Recommendations were graded using the FAME framework as Grade A (strong recommendation) or Grade B (weak recommendation). When evidence conflicted, priority was given to higher-quality, more recent evidence directly applicable to patients with DCM after CRT. Evidence derived from broader heart failure populations was considered indirect and downgraded unless DCM or CRT subgroup data were available.

Results

Search Results

Initially, 4562 records were identified. After removing duplicates and screening titles, abstracts, and full texts (Figure 1), 28 publications were included: 2 clinical decisions,15,16 10 guidelines,3,17–25 11 expert consensus or consensus documents,8,26–35 4 evidence summaries36–39 and 1 systematic review.9 Clinical decisions refer to evidence-based clinical decision support resources from UpToDate. The fundamental characteristics of the literature included are detailed in Table 3.

Figure 1.

A flowchart of literature retrieval, screening, exclusions and final inclusion of 28 items. Flowchart sequence: The literature was retrieved, n equals 4518, from CNKI, n equals 354; VIP, n equals 153; WanFang, n equals 936; Cochrane library, n equals 384; Web of Science, n equals 773; PubMed, n equals 1047; Embase, n equals 194; and Sinomed, n equals 677. Websites, n equals 44, from Medlive, n equals 19; AHA, n equals 3; CSC, n equals 2; CSANZ, n equals 2; ESC, n equals 4; AACVPR, n equals 1; NICE, n equals 1; SIGN, n equals 1; UpToDate, n equals 8; ACC, n equals 1; GIN, n equals 3; and link, n equals 1. Endnote removes duplicate literature, n equals 1023. Read title and abstract, n equals 3539. Excluded literature, n equals 3313, with bullet points, Inconsistent study topic, n equals 3285 and Incompatible literature, n equals 28. Read the full article and rescreen, n equals 226. Excluded literature, n equals 198. Included literature, n equals 28.

PubMed search strategy.

Abbreviations: AHA, American Heart Association; CSC, Chinese Society of Cardiology; CSANZ, Cardiac Society of Australia and New Zealand; ESC, European Society of Cardiology; AACVPR, American Association of Cardiovascular and Pulmonary Rehabilitation; NICE, National Institute for Health and Clinical Excellence; SIGN, Scottish Intercollegiate Guidelines Network; ACC, American College of Cardiology; GIN, Guidelines International Network.

Table 3.

General Characteristics of the Included Literature (n=28)

Author Publication Year/Latest Update Retrieval Source The Literature Theme Type of Literature
Ileana LP, et al15 2024 UpToDate Cardiac rehabilitation in patients with heart failure Clinical decision
Lynne TB, et al16 2024 UpToDate Cardiac rehabilitation programs Clinical decision
Makita et al17 2021 JCS/JACR Guideline on Rehabilitation in Patients with Cardiovascular Disease Guideline
Bigot et al18 2024 SFC Cardiac rehabilitation recommendations of the Group Exercise Rehabilitation Sports: 2023 update Guideline
Heiden et al19 2022 AHA/
ACC
Guideline for the Management of Heart Failure Guideline
Moe et al20 2013 CCS Heart Failure Management Guidelines Update Guideline
Arbelo et al21 2023 ESC Guidelines for the management of cardiomyopathies Guideline
Glikson et al3 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy Guideline
McDonagh et al22 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Guideline
Pelliccia et al23 2021 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease Guideline
SIGN24 2017 SIGN Cardiac rehabilitation: A national clinical guideline Guideline
Zhong Y et al25 2024 CNKI Cardiovascular Medicine of Sports and Exercise Guidelines Guideline
Brown et al26 2024 AHA Core Components of Cardiac Rehabilitation Programs: 2024 Update Consensus document
Paluch et al27 2024 AHA Resistance Exercise Training in Individuals with and without Cardiovascular Disease Consensus document
Verdicchio et al28 2023 CSANZ A Clinical Guide for Assessment and Prescription of Exercise and Physical Activity in Cardiac Rehabilitation Consensus document
Hansen et al29 2023 Medlive Standardised Exercise Prescription for Patients with Chronic Coronary Syndrome and/or Heart Failure Expert consensus
He J et al30 2024 CNKI Expert Consensus on Full-Cycle Rehabilitation for Elderly Patients with Chronic Heart Failure Expert consensus
Hu D et al31 2014 CARM Expert Consensus on Exercise Rehabilitation for Patients with Chronic Stable Heart Failure in China Expert consensus
Hu D et al32 2020 CARM Expert consensus on cardiac rehabilitation for chronic heart failure in China Expert consensus
Che L et al33 2022 CHA Expert Consensus on Hierarchical Diagnosis and Treatment of Cardiac Rehabilitation in China Expert consensus
Shen L et al8 2022 CNKI Chinese expert consensus on cardiac rehabilitation nursing care Expert consensus
Committee of Cardiac Rehabilitation and Prevention of Chinese Association of Rehabilitation Medicine et al34 2021 CARM China expert consensus on center guided home-based cardiac rehabilitation Expert consensus
Experts Consensus Group on Home-based Cardiac Rehabilitation in China.35 2022 CNKI Experts Consensus on Home-based Cardiac Rehabilitation in China Expert consensus
Wu D et al36 2024 CNKI Evidence summary of phase II cardiac rehabilitation for patients with chronic heart failure Evidence summary
Gao M et al37 2020 CNKI Summary of best evidence for exercise-based rehabilitation for heart failure Evidence summary
Zhao M et al38 2024 CNKI Evidence summary for pulmonary rehabilitation in patients with Chronic Heart Failure Evidence summary
Ruan T et al39 2023 CNKI Summary of the Best Evidence of Home-based Cardiac Rehabilitation in Patients with Chronic Heart Failure Evidence summary
Seo et al9 2019 PubMed Optimal Exercise Prescription for Patients with Dilated Cardiomyopathy in Cardiac Rehabilitation Systematic review

Abbreviations: JCS, Japanese Circulation Association, SFC, Société Française de Cardiologie, AHA, American Heart Association, CCS, Canadian Cardiovascular Society, ESC, European Society of Cardiology, SIGN, Scottish Intercollegiate Guidelines Network, CHCA, China Health Culture Association, CSANZ, Cardiac Society of Australia and New Zealand, CARM, Chinese Association of Rehabilitation Medicine, CHA, Chinese Hospital Association.

Quality Evaluation Results of the Included Literature

Quality Evaluation Results of Guidelines

Ten guidelines were included.3,17–25 Seven guidelines scored ≥60% in all six domains and were rated as level A; the remaining three guidelines were rated as level B. The methodological quality assessment is shown in Table 4.

Table 4.

Quality Evaluation results of Clinical Guidelines (n=10)

Guideline Q1 Q2 Q3 Q4 Q5 Q6 ≥60% ≥30% Recommendation Level
Makita et al17 94% 67% 92% 89% 63% 58% 5 6 B
Bigot et al18 100% 89% 58% 100% 88% 100% 5 6 B
Heiden et al19 100% 94% 90% 94% 88% 100% 6 6 A
Moe et al19 100% 94% 81% 94% 75% 100% 6 6 A
Arbelo et al21 100% 89% 94% 100% 88% 100% 6 6 A
Glikson et al3 100% 78% 85% 89% 79% 100% 6 6 A
McDonagh et al22 94% 78% 81% 94% 79% 100% 6 6 A
Pelliccia et al23 94% 89% 67% 94% 88% 100% 6 6 A
SIGN24 100% 89% 96% 89% 79% 100% 6 6 A
Zhong Y et al25 79% 63% 63% 89% 17% 33% 4 5 B

Note: Q1, scope and purpose, Q2, Stakeholder involvement, Q3, Rigour of development, Q4, Clarity of presentation, Q5, Applicability, Q6, Editorial independence.

Quality Evaluation Results of Systematic Reviews

One systematic review was included. The review by Seo et al9 did not evaluate publication bias. The items “Was the quality assessment of the literature performed independently by two or more reviewers?”, “Were measures taken to minimize error during data extraction?”, and “Was the method for evidence synthesis appropriate?” were rated as “Unclear”, whereas the remaining items were rated as “Yes”.

Quality Evaluation Results of Expert Consensus

Eleven expert consensus or consensus documents were included.8,26–35 The overall study design was comprehensive and of acceptable quality. The assessment findings are detailed in Table 5.

Table 5.

Quality Evaluation Results of Expert Consensus (n=11)

Expert Consensus Q1 Q2 Q3 Q4 Q5 Q6
Brown et al26 Yes Yes Unclear Unclear Yes Yes
Paluch et al27 Yes Yes Unclear Unclear Yes Yes
Verdicchio et al28 Yes Yes Unclear Unclear Yes Yes
Hansen et al29 Yes Yes Yes Yes Yes Yes
He J et al30 Yes Yes No Yes Yes Yes
Hu D et al31 Yes Yes No Yes Yes Yes
Hu D et al32 Yes Yes Unclear Unclear Yes Yes
Che L et al33 Yes Yes Unclear Unclear Yes Yes
Shen L et al8 Yes Yes Yes Yes Yes Yes
Hu D et al34 Yes Yes No Unclear Yes Yes
Fen X et al35 Yes Yes No Unclear Yes Yes

Note: Q1, Was the viewpoint put forward by influential experts in the relevant field? Q2, Was the statement of the viewpoint clear? Q3, Was the evidence base sufficient? Q4, Was the consensus-reaching process standardized? Q5, Was the focus centered on the interests of the relevant population? Q6, Could it be promoted and applied within certain contexts?

Quality Evaluation Results of Evidence Summaries

Four evidence summaries were included.36–39 Item 2 was rated as “Incomplete” in all included studies, and Item 3 was consistently rated as “No”. For Item 8, one study was rated as “Incomplete” and another as “No”. For Item 9, two studies were rated as “Incomplete”. Items 1, 4, 5, 6, 7, and 10 were rated as “Yes” across all studies. The overall quality was acceptable (Table 6).

Table 6.

Quality Evaluation Results of Evidence Summaries (n=4)

Evidence Summaries Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10
Wu D et al36 Yes Incomplete No Yes Yes Yes Yes Incomplete Yes Yes
Gao M et al37 Yes Incomplete No Yes Yes Yes Yes No Incomplete Yes
Zhao M et al38 Yes Incomplete No Yes Yes Yes Yes Yes Incomplete Yes
Ruan T et al39 Yes Incomplete No Yes Yes Yes Yes Yes Yes Yes

Notes: Q1: Was the scope and purpose clearly defined? Q2: Was authorship and contributor information transparent? Q3: Was information about reviewers and editors transparent? Q4: Was the search strategy transparent and comprehensive? Q5: Was evidence graded, and was the grading system transparent and comprehensible? Q6: Were the recommendations clearly articulated? Q7: Were the recommendations supported by appropriate references? Q8: Were the recommendations current? Q9: Was potential bias absent or adequately addressed? Q10: Was the evidence applicable to your patient population?

Evidence Aggregation and Generation

Finally, relevant evidence was extracted from the 28 included publications to form the first draft of the evidence summary. A total of 42 pieces of evidence items were obtained across 12 themes: multidisciplinary collaboration; indications and contraindications for exercise rehabilitation; pre-exercise assessment; pre-exercise preparation; exercise prescription; aerobic exercise; resistance training; pulmonary rehabilitation training; flexibility training; personalized adjustment; remote supervision and support; and emergency management (Table 7).

Table 7.

Summary of Evidence for Phase II Exercise-Based CR in Patients with DCM After CRT

Evidence Item Evidence Description Evidence Level Recommendation Level
Multidisciplinary Collaboration
  1. Establish a multidisciplinary collaborative team comprising cardiologists, cardiac rehabilitation therapists, nurses, psychological counselors, nutritionists, and pharmacists to collaboratively develop and implement exercise-based CR plans.8,17,19,26,28–31,33,34,36

Level 1 A
Exercise Indications and Contraindications
  • 2

    Indications:15–17,19,20,23,26,32,36,37,39 Post-CRT patients with DCM who met all three criteria, namely, stable clinical condition (NYHA functional class I-III), a properly functioning CRT device, and no incision infection.

Level 1 B
  • 3

    Contraindications:16–18,31,32,34,37–39 ① Acute cardiovascular conditions: unstable angina, acute aortic dissection, new-onset atrial fibrillation, decompensated heart failure, uncontrolled arrhythmia or hypertension (>180/110 mmHg), or sinus tachycardia at rest (>120 beats/min); ② Cardiovascular structural abnormalities or severe complications: severe pulmonary hypertension (>55 mmHg), severe symptomatic aortic stenosis (aortic valve area <1.0 cm2), recent embolism, thrombophlebitis; ③Metabolic and infectious diseases: hypokalemia, hyperkalemia, or hypovolemia (until adequately treated), active myocarditis, pericarditis, or endocarditis, acute systemic illness or fever, recent diarrhea, and other metabolic diseases such as acute thyroiditis;④ Symptomatic and functional limitations: severe orthopedic diseases, progressive deterioration of exercise tolerance with dyspnea at rest or after exercise (eg, dizziness, chest pain, abnormal fatigue, unusual shortness of breath, or palpitations).

Level 1 A
Evaluation
  • 4

    Contents:15–18,23,26,32–36 ①History of cardiovascular disease (CVD) and other organ diseases, as well as various risk factors, including hypertension, diabetes, hyperlipidemia, obesity, and smoking history. ②Evaluate symptoms and signs such as chest pain, chest tightness, shortness of breath, palpitations, and lower extremity edema. ③Assessment NYHA cardiac function classification, physical examination emphasizing cardiopulmonary endurance and the musculoskeletal system, and recent cardiovascular examination results, including blood biochemistry, electrocardiograms, and echocardiograms. ④Assess pacemaker or implantable cardioverter defibrillator function, daily exercise habits, and medication use.

Level 1 B
  • 5

    Employ assessment tools, including the Fear of Movement Scale for Heart Disease Patients and the Generalized Anxiety Disorder Scale, to identify patients with kinesophobia or anxiety. Subsequently, offer educational interventions such as solution-focused therapy, cognitive behavioral therapy, and acceptance and commitment therapy.8,15,16,22,24,26,28,32,33,36

Level 1 A
6. Assess patients’ willingness, cognitive capacity, family support, and movement disorders related to cardiac rehabilitation exercises using questionnaires or interviews.16–18,24,26,28,30,33,34,36,39 Level 3 A
7. Prioritize cardiopulmonary exercise testing to evaluate exercise capacity and develop appropriate exercise prescriptions. If cardiopulmonary exercise testing is not feasible, consider the 6MWT as an alternative.17,19,26,32,33,36 Level 1 A
Preparation 8. Wear comfortable footwear and loose-fitting clothing, and ensure that the surrounding environment is safe.24,26,28,37 Level 1 A
9. Conduct an immediate assessment of physical condition by monitoring resting heart rate, blood pressure, and blood oxygen saturation before exercise to exclude any acute discomfort.15,16,28,36 Level 3 A
Arrangement 10. Warm-up Stage:16–18,28,32,36,37 5–10 minutes, primarily emphasizing stretching, flexibility, or joint movement, along with low-intensity aerobic exercises to gradually elevate the heart rate to the target range. Level 2 A
11. Training Stage:16–18,36,37 5–20 minutes, predominantly comprising continuous or intermittent aerobic exercises, supplemented by resistance training. Level 2 A
12. Consolidation stage:17,18,28,32,36,37 5–10 minutes, featuring low-intensity exercise to facilitate gradual recovery following the training stage. Level 2 A
Aerobic exercise 13. Exercise frequency:16,17,28–31,35–38 3–5 times per week. Level 2 A
14. Exercise intensity:9,25 ① Low-intensity exercise: 37–45% of VO2max, 30–39% of VO2R or HRR, a Borg scale score between 9 and 11, or 3–5 METs; ② Moderate-intensity exercise: 46–63% of VO2max, 40–59% of VO2R or HRR, a Borg scale score between 12 and 13, or 5–7 METs. Level 1 A
15. Exercise duration:20,30 ①For interval training, 5–10 minutes per session, with a total duration of approximately 20–30 minutes; ②For continuous training, 20–30 minutes per session. Level 1 A
16. Types of exercise:16,20,26,28,31,33,34,36,37,39 ①Aerobic exercises include walking, jogging, cycling, dancing, rowing, Tai Chi, and stair climbing are included. Among these, walking is the simplest and most accessible form of exercise, making it the recommended first choice. ②Contact sports, such as rugby or martial arts, should be avoided to prevent damage to device components or hematoma formation at the implantation site. ③ Intense vibration exercises, such as combat training, should be avoided to prevent inappropriate decide discharges. Swimming should be avoided for 6 weeks after device implantation. Level 3 A
17. Physical activity:34 ①The amount of physical activity should be evaluated for each session and weekly (frequency × intensity × time); ②This can be quantified in terms of calories or MET× minute activity volume, which nurses can calculate based on the patient’s exercise regimen or by utilizing professional exercise assessment software or equipment. Level 1 A
18. Advanced exercise:9,16,17,28–30,32 ①Begin training at low intensity and gradually increase intensity; ②Each session should include one component from frequency, intensity, or duration. After two consecutive weeks without discomfort, aim to extend the duration by 1–5 minutes. Once the established standard is reached, subsequently increase the intensity by 5%-10%. Level 2 A
Resistance exercise 19. Exercise frequency:16–18,20,25–29,32,33,39 Engage in training 2–3 times per week, with sessions occurring every other day. Level 2 B
20. Exercise intensity:16,17,25,33 ①The gold standard for determining resistance exercise intensity is the one-repetition maximum (1RM) test. In the absence of resistance machines or equipment, the Borg scale may serve as an alternative measurement tool. ②For low to moderate intensity, upper limb exercises should be performed at 30–40% of 1RM, while lower limb exercises should be conducted at 40–50% of 1RM, with 10–15 repetitions per set and a Borg scale score of ≤13. Level 1 B
21. Exercise duration:9,16,17,20,37 ①Four weeks post-operation, provided there is no sternum instability or incision infection, low-intensity resistance training may be implemented as an adjunct to facilitate patient recovery; ②Allow a 60-second rest between sets, with a total exercise duration ranging from 5–20 minutes. Level 5 B
22. Type of Exercise:17,26,33,34,39 ①Utilize safe and comfortable equipment designed for personal use. For strength training at home, options include dumbbells, resistance bands, free weights, leg stretches, curls, presses, bench or seated rows, and heel lifts. These exercises target the strength of the upper limbs, lower limbs, and core muscle groups. ②Avoid sternal weight-bearing training for six weeks following the operation. Level 1 B
23. Exercise Volume:16,17,26,28,32 The training volume for each muscle group should consist of 15–36 repetitions, organized into 1–3 sets, with each set containing 8–15 repetitions. Level 5 B
24. Advanced Exercise:28,32 ①Begin with low intensity and short duration; ②To optimize training effects, first increase training volume (repetitions and sets), followed by an increase in intensity (weight), and finally adjust other aspects. Level 2 B
Pulmonary rehabilitation training 25. Exercise frequency:30 1–2 times per day. Level 2 B
26. Exercise duration:38 Initiate early progressive replacement training for patients exhibiting exercise intolerance or those who refrain from physical activity due to kinesophobia, prior to transitioning to aerobic and resistance training; each session should last 5–10 minutes. Level 2 B
27. Type of exercise:16,17,28,39 Implement breathing retraining and relaxation breathing techniques, while avoiding Valsalva maneuvers. Level 2 B
Flexible exercise 28. Exercise frequency:33,39 daily. Level 2 B
29. Exercise intensity:33,39 no significant pain. Level 5 B
30. Exercise duration:33,37,39 5–10 minutes per session. Level 1 A
31. Type of exercise:32,33,39 exercises involving large joints and major muscle groups, including static or dynamic stretching (eg, head and neck exercises, shoulder rotations). Level 5 A
Dynamic Assessment and Individualized Adjustment 32. Throughout the implementation process, the exercise prescription is dynamically modified to account for individual patient differences and rehabilitation progress, including adjustments to exercise intensity, duration, and frequency, thereby ensuring the safety and efficacy of exercise-based CR.16–18,22,28 Level 1 A
33. Regular reassessments are recommended, with medium and high-risk patients undergoing evaluations monthly, while low-risk patients should be assessed every three months. These evaluations may include cardiopulmonary exercise testing or 6MWT, and the exercise prescription should be adjusted based on changes in VO2peak and LVEDD.35,36 Level 2 A
34. Periodic assessments of the patient’s current motor status and movement disorders should be conducted, with appropriate interventions implemented as needed.16,17,24,28 Level 3 A
35. Strengthening the management of comorbidities:16,18,32 ①Hypertensive patients should maintain blood pressure <160/100 mmHg prior to exercise and avoid abrupt changes in body position during physical activity; ②Diabetic patients must adjust their fasting blood glucose levels to between 5.6–13.9 mmol/L before initiating exercise; ③Obese patients with a BMI of ≥28 kg/m2 should prioritize low-impact exercises to enhance fat loss efficiency; ④Patients with malnutrition should focus on nutritional support before gradually increasing activity levels. Level 5 B
36. Countermeasures for ineffective plans:17 Reassess risk stratification, initiate multidisciplinary consultations, and revise exercise prescriptions accordingly. Level 2 A
37. Withdrawal and referral:30 If the NYHA class deteriorates to class IV or if ventricular arrhythmia occurs, patients should be transferred to a higher-level hospital’s heart failure center. Level 5 B
Remote supervision and support 38. The use of wearable devices, such as heart rate monitors and smart bracelets, is recommended for real-time monitoring of heart rate, blood pressure, and blood oxygen saturation.16,17,20,22,26,28,32–34,36,39 Level 5 B
39. An early warning mechanism should be established, setting the upper limit of heart rate at 85% of the reserve heart rate, with a Borg scale score of ≥15 or a SpO2 <90% serving as alarm thresholds, and linking to an emergency contact person.16,17 Level 1 A
40. An Internet platform should be utilized for remote supervision to share rehabilitation knowledge, dynamically assess exercise behavior, encourage peer exchange of exercise experiences, support family involvement, and enhance patients’ exercise compliance and rehabilitation outcomes.8,16,18,20,24,34 Level 1 B
Emergency response: 41. Chest pain:34 Cease exercise immediately and place nitroglycerin under the tongue. If the pain persists after 10 minutes, activate the emergency response plan. Level 5 B
42. Dizziness, rapid heart rate, nausea, etc.: Lie flat to rest, monitor vital signs, and consult a specialist for treatment if needed.28,34 Level 3 A

Abbreviations: NYHA, New York Heart Association, HRR, Heart Rate Recovery, LVEDD, Left Ventricular End-Diastolic Diameter, Borg scale, Borg Rating of Perceived Exertion (RPE) scale.

Discussion

Structured exercise-based CR is a fundamental component of comprehensive CR. Recent studies have incorporated advanced exercise technologies to tailor interventions to individual patient needs and enhance exercise prescription. Despite well-documented benefits, discrepancies persist between patient practices and exercise guidelines, potentially leading to complications. Therefore, evidence-based approaches are crucial to enhance nursing practice and bridge theory with implementation. Given the limited number of CR studies specifically in patients with DCM, most included studies enrolled broader heart failure populations. Therefore, the following recommendations should be interpreted with caution when applied specifically to patients with DCM after CRT. Each evidence item discussed below corresponds to the numbered rows in Table 7.

Multidisciplinary Collaboration Is the Prerequisite for Safe Rehabilitation

Evidence item 1 (Table 7) emphasizes the importance of multidisciplinary collaboration in Phase II exercise-based CR for patients with DCM after CRT. This phase predominantly involves a blend of outpatient and home-based self-rehabilitation to facilitate recovery and societal reintegration.17 Phase II exercise-based CR is delivered under healthcare professional supervision and is generally safe, but its participation rate remains suboptimal at approximately 40%.40 This is largely attributable to longstanding barriers such as geographical distance, transportation difficulty, limited availability of rehabilitation centers, and socioeconomic disadvantage.41 Therefore, patients should undergo Phase II exercise-based CR under the guidance of a multidisciplinary rehabilitation team.

Research indicates that a multidisciplinary team comprising cardiologists, rehabilitation physicians, nurses, nutritionists, and psychotherapists can develop personalized rehabilitation plans covering disease management, rehabilitation assessment, exercise guidance, nutritional support, and psychological intervention.16 Evidence also suggests that supervised exercise rehabilitation by such a team can improve exercise capacity and cardiac function.15 However, at the current stage, multidisciplinary team collaboration remains fragmented, with problems including role confusion among healthcare professionals and insufficient professional expertise.36 Therefore, it is recommended to clarify the roles and collaboration procedures of each team member, optimize human resource allocation, and address current deficiencies in CR teams. Nurses can play a central coordinating role by screening for eligibility, monitoring exercise safety, delivering education, and linking patients with rehabilitation specialists.36,39 Nevertheless, the available evidence is largely derived from broader heart failure populations, and direct evidence specific to DCM after CRT remains limited. Future studies should evaluate the feasibility and effectiveness of multidisciplinary rehabilitation models specifically in this population.

Comprehensive Assessment and Risk Stratification Should Precede Exercise Prescription

Comprehensive assessment and risk stratification are the foundation of safe and effective Phase II exercise-based CR in patients with DCM after CRT. Evidence items 2 and 3 (Table 7) define the indications and contraindications for exercise rehabilitation and establish a safety framework for judging when exercise should be initiated, deferred, or modified. This is particularly important in DCM after CRT because device function, left ventricular reverse remodeling, exercise tolerance, and arrhythmic risk may change over time.18,31,34,37 Assessment limited to LVEF or NYHA class would therefore fail to capture the factors that determine whether a patient can exercise safely and consistently.

Assessment should be multidimensional. Evidence items 5–7 (Table 7) suggest that pre-exercise evaluation should include cardiac function, exercise endurance, psychological state, social support, cognitive capacity, nutritional status, medication use, and device function.16,25 Research has shown that satisfying patients’ exercise-related psychological needs can directly affect their exercise adherence.42 Depression and anxiety may reduce exercise adherence, and physical activity levels have been shown to decline within six months after initiating exercise-based CR in patients with depression.24 In addition, cognitive behavioral therapy may improve exercise self-efficacy.8 Caregiver involvement can be supportive, but may also increase patient anxiety, especially among female patients.24 Pre-exercise assessment should therefore include psychological status, caregiver readiness, and social support, and in particular, structured caregiver education should be integrated into rehabilitation treatment plans. Notably, to ensure the safety and effectiveness of Phase II exercise-based CR, assessment should be dynamic rather than a one-time activity. Evidence items 4 and 5 (Table 7) support repeated evaluation of symptoms, device function, exercise habits, and medication use. However, this evidence is of lower quality, and the optimal timing of reassessment remains unclear.

Exercise Prescription Based on FITT-VP

The FITT-VP principle (Frequency, Intensity, Time, Type, Volume, and Progression) offers a structured framework to guide exercise prescriptions, ensuring both safety and effectiveness.23,37 Evidence items 10–16 (Table 7) divide a workout session into warm-up, training, and cool-down stages, aligning with physiological adaptation principles to prevent injuries and enhance recovery. Tailoring exercise frequency, duration, and intensity to factors such as NYHA functional class and endurance level is recommended.23,24 The NYHA functional classification is defined as follows: Class I, no limitation of physical activity; Class II, slight limitation of physical activity; Class III, marked limitation of physical activity; Class IV, inability to perform any physical activity without discomfort.15,16 Patients with NYHA class II can increase exercise frequency and duration, while those with NYHA class III should carefully manage exercise intensity to avoid overexertion.16,31 Studies indicate that moderate exercise may enhance cardiac function and quality of life in patients with DCM after optimal treatment.9 However, high-intensity exercise may trigger serious arrhythmias in patients with DCM, underscoring the importance of balancing risks and benefits.22

Aerobic exercise is a fundamental form of physical activity. Evidence item 17 (Table 7) emphasizes that moderate-intensity activities, including walking, jogging, and Tai Chi, should be prioritized, with exercise intensity maintained at 40–59% of maximum heart rate. This approach may enhance cardiopulmonary function and mitigate the risk of adverse cardiovascular events.36,37 Despite traditional concerns about the safety of resistance exercise,28 findings from this evidence synthesis indicate that when cardiac function is rigorously evaluated and exercise intensity is controlled, resistance training may effectively improve muscle strength, exercise endurance, and quality of life.17,26 Complementary methods such as pulmonary rehabilitation training and flexibility exercises target potential respiratory issues and muscle and joint rigidity,23,31 respectively, augmenting the rehabilitation regimen and underscoring the holistic nature of exercise-based rehabilitation. However, most evidence was derived from broader heart failure populations, and the optimal exercise intensity, duration, and progression for patients with DCM after CRT remain uncertain.

Dynamic Adjustment and Emergency Response

Although exercise-based CR has numerous benefits, individual physiological responses to standardized exercise regimens vary greatly, and adverse events may occur that could impede or interrupt the rehabilitation process.43 Because of individual differences and variations in rehabilitation progress, exercise plans should not be static. They should be adjusted promptly based on patients’ responses during exercise and fluctuations in their condition.39 A systematic review reported that the incidence of musculoskeletal problems was 57.5% among patients enrolled in cardiovascular rehabilitation programs, and recommended that exercise training plans be dynamically adjusted according to patients’ functional limitations.44

Emergency preparedness is particularly important in patients with DCM after CRT because they may be at risk of arrhythmia, hypotension, device-related complications, or heart failure decompensation.16,18 Thus, before commencing exercise-based CR, comprehensive health education should be delivered promptly to patients and their families, equipping them with an understanding of possible discomfort indicators and corresponding treatment strategies. Concurrently, healthcare providers should develop contingency plans for adverse events such as angina, arrhythmia, and hypotension within the exercise rehabilitation facility, along with specialized training in knowledge and skills.31 These actions may mitigate hazards associated with exercise-based CR and bolster the confidence of both patients and medical personnel. However, the evidence for emergency management is largely based on expert consensus, and unified protocols for emergency response in DCM after CRT are lacking.

Telemedicine and Remote Supervision May Enhance Adherence and Accessibility

Evidence items 38–40 (Table 7) support the use of wearable devices, early warning mechanisms, and Internet platforms for remote supervision of home-based exercise rehabilitation. Remote supervision can promptly detect abnormal conditions by monitoring exercise intensity, heart rate, blood pressure, and other indicators, and can provide exercise guidance and address patients’ inquiries through online platforms, potentially enhancing safety and adherence.45,46 This approach aligns with the current trend of medical informatization and particularly benefits patients in remote areas with limited transportation access.46 Nevertheless, low technology acceptance and poor usage adherence among elderly patients, as well as concerns over data security and privacy, remain major barriers.47 Future studies should explore user-friendly and secure telemedicine models specifically for patients with DCM after CRT, including mini-programs, mobile applications, and wearable devices with validated alert thresholds.

Limitations

This study has several limitations. First, most included studies enrolled broader heart failure populations rather than exclusively patients with DCM after CRT; direct evidence specific to this population remains limited. Second, the included evidence types were heterogeneous, and different appraisal and grading systems were used. Third, only Chinese and English publications were included, which may introduce language bias. Therefore, recommendations should be individualized according to patient characteristics, device status, and clinical context.

Conclusion

This study synthesized 42 evidence items on Phase II exercise-based CR for patients with DCM after CRT, covering multidisciplinary collaboration, indications and contraindications, pre-exercise assessment and preparation, exercise prescription, aerobic and resistance exercise, pulmonary rehabilitation, flexibility training, personalized adjustment, remote supervision, and emergency management. In summary, this evidence summary establishes a structured framework for Phase II exercise-based CR in patients with DCM after CRT, while highlighting that the strength of recommendations is constrained by the indirectness of the available evidence. However, most evidence was derived from broader heart failure populations, and direct evidence specific to DCM after CRT remains limited. These findings may inform the development of individualized rehabilitation protocols, but healthcare facilities should evaluate feasibility, applicability, and safety before implementation. Future research should focus on DCM-CRT-specific exercise protocols and telemedicine-based adherence strategies.

Funding Statement

This study was supported by the Cuiying Science and Technology Innovation Project of Lanzhou University Second Hospital (No. CY2025-HL-A07), the Gansu Provincial Health Industry Scientific Research Program (No. GSWSHL2022-33; No. GSWSHL2024-28) and the Chinese Nursing Association Project (No. ZHKYQ202303).

Disclosure

Co-first Authorship: Xinglei Wang and Yunyun Liu contributed equally to this manuscript. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  • 1.Heymans S, Lakdawala NK, Tschöpe C, Klingel K. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet. 2023;402(10406):998–16. doi: 10.1016/s0140-6736(23)01241-2 [DOI] [PubMed] [Google Scholar]
  • 2.Presentation WLDDC. Early outcomes, and female sex: a paradox revealed. JACC Heart Fail. 2024;12(2):364–365. doi: 10.1016/j.jchf.2023.11.013 [DOI] [PubMed] [Google Scholar]
  • 3.Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: developed by the task force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) with the special contribution of the European Heart Rhythm Association (EHRA). Eur Heart J. 2021;42(35):3427–3520. doi: 10.1093/eurheartj/ehab364 [DOI] [PubMed] [Google Scholar]
  • 4.Grosman-Rimon L, Hui S, Santos S, et al. Exercise rehabilitation in cardiac resynchronization: systematic review and a meta-analysis. Heart Fail Rev. 2021;26(3):507–519. doi: 10.1007/s10741-020-10049-7 [DOI] [PubMed] [Google Scholar]
  • 5.Linde C, Ellenbogen K, McAlister FA. Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations. Heart Rhythm. 2012;9(8 Suppl):S3–s13. doi: 10.1016/j.hrthm.2012.04.026 [DOI] [PubMed] [Google Scholar]
  • 6.Pothineni NVK, Gondi S, Cherian T, et al. Complications of cardiac resynchronization therapy: comparison of safety outcomes from real-world studies and clinical trials. J Innov Card Rhythm Manag. 2022;13(8):5121–5125. doi: 10.19102/icrm.2022.130805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.MacEachern E, Quach J, Giacomantonio N, et al. Cardiac rehabilitation and frailty: a systematic review and meta-analysis. Eur J Prev Cardiol. 2024;31(16):1960–1976. doi: 10.1093/eurjpc/zwae239 [DOI] [PubMed] [Google Scholar]
  • 8.Shen L, Meng X, Chen X, Zhu L, Wang M, Cao Y. Chinese expert consensus on cardiac rehabilitation nursing care. Chin J Nurs. 2022;57(16):1937–1941. doi: 10.3761/j.issn.0254-1769.2022.16.003 [DOI] [Google Scholar]
  • 9.Seo YG, Jang MJ, Lee GY, Jeon ES, Park WH, Sung JD. What is the optimal exercise prescription for patients with dilated cardiomyopathy in cardiac rehabilitation? A Systematic Review. J Cardiopul Rehab Prevent. 2019;39(4):235–240. doi: 10.1097/hcr.0000000000000382 [DOI] [PubMed] [Google Scholar]
  • 10.Chen G, Shen C, Pan C, Gao X, Sun M, Li X. Summary of best evidence for safe management of vasopressors through peripheral intravenous catheters. BMC Nurs. 2025;24(1):1000. doi: 10.1186/s12912-025-03635-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Windish D. Searching for the right evidence: how to answer your clinical questions using the 6S hierarchy. Evid Based Med. 2013;18(3):93–97. doi: 10.1136/eb-2012-100995 [DOI] [PubMed] [Google Scholar]
  • 12.Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Cmaj. 2010;182(18):E839–42. doi: 10.1503/cmaj.090449 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–140. doi: 10.1097/xeb.0000000000000055 [DOI] [PubMed] [Google Scholar]
  • 14.Foster MJ, Shurtz S. Making the Critical Appraisal for Summaries of Evidence (CASE) for evidence-based medicine (EBM): critical appraisal of summaries of evidence. J Med Libr Assoc. 2013;101(3):192–198. doi: 10.3163/1536-5050.101.3.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Piña IL. Cardiac rehabilitation in patients with heart failure. 2026.
  • 16.Braun LT. Cardiac rehabilitation programs. 2026.
  • 17.Makita S, Yasu T, Akashi YJ, et al. CORRIGENDUM: JCS/JACR 2021 guideline on rehabilitation in patients with cardiovascular disease. Circ J. 2023;87(6):937. doi: 10.1253/circj.CJ-66-0214 [DOI] [PubMed] [Google Scholar]
  • 18.Bigot M, Guy JM, Monpere C, et al. Cardiac rehabilitation recommendations of the Group Exercise Rehabilitation Sports – prevention (GERS-P) of the French Society of Cardiology: 2023 update. Arch Cardiovasc Dis. 2024;117(8–9):521–541. doi: 10.1016/j.acvd.2024.05.119 [DOI] [PubMed] [Google Scholar]
  • 19.Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18). doi: 10.1161/cir.0000000000001063 [DOI] [PubMed] [Google Scholar]
  • 20.Moe GW, Ezekowitz JA, O’Meara E, et al. The 2013 Canadian cardiovascular society heart failure management guidelines update: focus on rehabilitation and exercise and surgical coronary revascularization. Canad J Cardiol. 2014;30(3):249–263. doi: 10.1016/j.cjca.2013.10.010 [DOI] [PubMed] [Google Scholar]
  • 21.Arbelo E, Protonotarios A, Gimeno JR, et al. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503–3626. doi: 10.1093/eurheartj/ehad194 [DOI] [PubMed] [Google Scholar]
  • 22.McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. doi: 10.1093/eurheartj/ehab368 [DOI] [PubMed] [Google Scholar]
  • 23.Pelliccia A, Sharma S, Gati S, et al. 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17–96. doi: 10.1093/eurheartj/ehaa605 [DOI] [PubMed] [Google Scholar]
  • 24.SIGN. Cardiac rehabilitation: a national clinical guideline. 2017.
  • 25.Zhong Y, Dun Y, Wei W, Wang Q, Gao H, Zhang Q. Cardiovascular medicine of sports and exercise guidelines. Chin Circ J. 2024;39(10):937–955. doi: 10.3969/j.issn.1000-3614.2024.10.001s [DOI] [Google Scholar]
  • 26.Brown TM, Pack QR, Aberegg E, et al. Core components of cardiac rehabilitation programs: 2024 update: a scientific statement from the American heart association and the American association of cardiovascular and pulmonary rehabilitation. Circulation. 2024;150(18). doi: 10.1161/cir.0000000000001289 [DOI] [PubMed] [Google Scholar]
  • 27.Paluch AE, Boyer WR, Franklin BA, et al. Resistance exercise training in individuals with and without cardiovascular disease: 2023 update: a scientific statement from the American heart association. Circulation. 2024;149(3):e217–e231. doi: 10.1161/cir.0000000000001189 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Verdicchio C, Freene N, Hollings M, et al. A clinical guide for assessment and prescription of exercise and physical activity in cardiac rehabilitation. A CSANZ position statement. Heart,Lung Circ. 2023;32(9):1035–1048. doi: 10.1016/j.hlc.2023.06.854 [DOI] [PubMed] [Google Scholar]
  • 29.Hansen D, Beckers P, Neunhäuserer D, et al. Standardised exercise prescription for patients with chronic coronary syndrome and/or heart failure: a consensus statement from the EXPERT working group. Sports Med. 2023;53(11):2013–2037. doi: 10.1007/s40279-023-01909-x [DOI] [PubMed] [Google Scholar]
  • 30.He J, Jia J, Chen X, et al. Expert consensus on full-cycle rehabilitation for elderly patients with chronic heart failure. Rehab Med. 2025;35(2):112–123. doi: 10.3724/SP.J.1329.2025.02002 [DOI] [Google Scholar]
  • 31.Committee of Cardiovascular Disease of Chinese Association of Rehabilitation Medicine, Geriatrics. CoC-CDoCAoGa. China expert consensus on exercise rehabilitation for chronic stable heart failure. Chin Circ J. 2014;42(9):714–720. doi: 10.3969/j.issn.1000-3614.2014 [DOI] [PubMed] [Google Scholar]
  • 32.PCoCPaRoC R, M A. Expert consensus on cardiac rehabilitation for chronic heart failure in China. Chin J Intern Med. 2020;59(12):942–952. doi: 10.3760/cma.j.cn112138-20200309-00210 [DOI] [PubMed] [Google Scholar]
  • 33.Che L, Dai C, Liu W, et al. Chinese expert consensus on hierarchical diagnosis and treatment of cardiac rehabilitation. Chin J Intervent Cardiol. 2022;30(8):561–572. doi: 10.3969/j.issn.1004-8812.2022.08.001 [DOI] [Google Scholar]
  • 34.Committee of Cardiac Rehabilitation and Prevention of Chinese Association of Rehabilitation Medicine, Committee of Cardiovascular Disease of China Association of Gerontology and Geriatrics. China expert consensus on center guided home-based cardiac rehabilitation. Chin J Intern Med. 2021;60(3):207–215. doi: 10.3760/cma.j.cn112138-20200629-00630 [DOI] [PubMed] [Google Scholar]
  • 35.Experts Consensus Group on Home-based Cardiac Rehabilitation in China. Experts consensus on home-based cardiac rehabilitation in China. Chin Circ J. 2022;37(2):108–121. doi: 10.3969/j.issn.1000-3614.2022.02.002 [DOI] [Google Scholar]
  • 36.Wu D, Tao M, Chen Y, Chen Y, Wu H, Zhang L. Evidence summary of phase II cardiac rehabilitation for patients with chronic heart failure. Chin J Emerg Critic Care Nurs. 2024;5(3):222–229. doi: 10.3761/j.issn.2096-7446.2024.03.005 [DOI] [Google Scholar]
  • 37.Gao M, Sun G, Xing S, Gu Z. Summary of best evidence for exercise-based rehabilitation for heart failure. J Nurs Sci. 2020;35(4):10–15. doi: 10.3870/j.issn.1001-4152.2020.04.010 [DOI] [Google Scholar]
  • 38.Zhao M, Wei L, Lu X, et al. Evidence summary for pulmonary rehabilitation in patients with chronic heart failure. Chin Nurs Manag. 2024;24(3):425–430. doi: 10.3969/j.issn.1672-1756.2024.03.020 [DOI] [Google Scholar]
  • 39.Ruan T, Ding Y, Xu M, Zhu L. Summary of the best evidence of home-based cardiac rehabilitation in patients with chronic heart failure. Pract J Cardiac Cerebral Pneumal. 2023;31(8):97–103. [Google Scholar]
  • 40.Raisi A, Zerbini V, Tonet E, et al. Physical performance and outcomes after myocardial infarction in older patients undergoing multidomain cardiac rehabilitation. Eur J Prev Cardiol. 2026. doi: 10.1093/eurjpc/zwag390 [DOI] [PubMed] [Google Scholar]
  • 41.Ma S, Zhang J, Yan Y, et al. Home-based cardiac rehabilitation in cardiovascular diseases: a narrative review of progress, challenges, and future directions. J Multidiscip Healthc. 2026;19:603912. doi: 10.2147/jmdh.S603912 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Yang Z, Huang H, Xu L, Gao Y, Zhang C, Wang A. From need to action: decoding the role of motivation in adherence to home-based cardiac rehabilitation exercise in chronic heart failure patients. BMC Nurs. 2024;23(1):913. doi: 10.1186/s12912-024-02617-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Milani J, Milani M, D’Ascenzi F, et al. Cardiorespiratory exercise intensity prescription in cardiovascular rehabilitation: do updated guideline recommendations reflect real individual effort responses? Eur J Prev Cardiol. 2026. doi: 10.1093/eurjpc/zwag311 [DOI] [PubMed] [Google Scholar]
  • 44.Straioto Salomão A, Soares Piquione F, de Oliveira C BS, Gonçalves Toledo AC C. Prevalence of musculoskeletal conditions in heart patients undergoing cardiovascular rehabilitation programs: a systematic review and meta-analysis. Cureus. 2025;17(10):e94542. doi: 10.7759/cureus.94542 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Singhal A, Cowie MR. Digital health: implications for heart failure management. Card Fail Rev. 2021;7:e08. doi: 10.15420/cfr.2020.28 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Meng Z, Li J, Yang J, et al. Digital health technology for improving physical function in adults with chronic heart failure: systematic review and meta-analysis of randomized controlled trials. J Med Internet Res. 2026;28:e91820. doi: 10.2196/91820 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Zhu X, Liu L, Wang Y, et al. Application of digital health technologies in cardiac rehabilitation for patients with coronary heart disease: scoping review. J Med Internet Res. 2026;28:e85917. doi: 10.2196/85917 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Multidisciplinary Healthcare are provided here courtesy of Dove Press

RESOURCES